| Hypoxia-targeted gold nanorods for cancer photothermal therapy Y Chen, X Bian, M Aliru, AA Deorukhkar, O Ekpenyong, S Liang, J John, ... Oncotarget 9 (41), 26556, 2018 | 31 | 2018 |
| Development and validation of a novel LC-MS/MS method for the simultaneous determination of abemaciclib, palbociclib, ribociclib, anastrozole, letrozole, and fulvestrant in … L Turković, L Bočkor, O Ekpenyong, T Silovski, M Lovrić, S Crnković, ... Pharmaceuticals 15 (5), 614, 2022 | 18 | 2022 |
| Pre-clinical pharmacokinetics, tissue distribution and physicochemical studies of CLBQ14, a novel methionine aminopeptidase inhibitor for the treatment of infectious diseases O Ekpenyong, X Gao, J Ma, C Cooper, L Nguyen, OA Olaleye, D Liang, ... Drug Design, Development and Therapy, 1263-1277, 2020 | 10 | 2020 |
| Pharmacokinetic behaviors of soft nanoparticulate formulations of chemotherapeutics M Sarkar, Y Wang, O Ekpenyong, D Liang, H Xie Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 15 (2 …, 2023 | 8 | 2023 |
| A simple, sensitive and reliable LC-MS/MS method for the determination of 7-bromo-5-chloroquinolin-8-ol (CLBQ14), a potent and selective inhibitor of methionine aminopeptidases … O Ekpenyong, C Cooper, J Ma, D Liang, O Olaleye, H Xie Journal of Chromatography B 1097, 35-43, 2018 | 8 | 2018 |
| Bioanalytical assay development and validation for the pharmacokinetic study of gmc1, a novel fkbp52 co-chaperone inhibitor for castration resistant prostate cancer O Ekpenyong, C Cooper, J Ma, NC Guy, AN Payan, F Ban, A Cherkasov, ... Pharmaceuticals 13 (11), 386, 2020 | 3 | 2020 |
| A surrogate matrix-based approach toward multiplexed quantitation of an sGC stimulator and cGMP in ocular tissue and plasma K Lin, P Cabral, O Ekpenyong, SE Bader, J Galvao, Y Kim, SX Lu, YT Tam, ... Toxicologic Pathology 49 (3), 544-554, 2021 | 1 | 2021 |
| Intravenous formulation and LC/MS/MS analysis method for GMC1 M Cox, H Xie, O Ekpenyong US Patent 10,010,534, 2018 | 1 | 2018 |
| Early development of GMC1, a novel molecule targeting FKBP52 for the treatment of hormone-refractory prostate cancer H Xie, O Ekpenyong Cancer Research 77 (13_Supplement), 176-176, 2017 | 1 | 2017 |
| Development of a capillary electrophoresis method for the simultaneous determination of CDK 4/6 and aromatase inhibitors L Turković, B Nigović, T Silovski, O Ekpenyong, S Crnković, M Sertić Recent Developments in Pharmaceutical Analysis (RDPA 2021), 110-110, 2021 | | 2021 |
| Pre-Clinical Studies of GMC1, a Novel Molecule Targeting FKBP52 for the Treatment of Castration Resistant Prostate Cancer, and CLBQ14 Targeting Methionine Amino-Peptidase for … O Ekpenyong Texas Southern University, 2017 | | 2017 |
Xiuqing GaoAlnylam PharmaceuticalsVerified email at alnylam.com
